| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Early diagnosis and treatment of acute hepatitis C (HCV) |
Phillips, R.S.;Hookman, P.;Barkin, J.S.; |
The American Journal of Gastroenterology |
2000-09-01 |
查看 |
| Recommendations for greater accuracy in the standard of care for thedetection of early Barrett's esophageal cancer ^1 |
Hookman, P.;Barkin, J.S.; |
The American Journal of Gastroenterology |
2002-05-01 |
查看 |
| What should be the standard of care for cancer surveillance, diagnosis ofdysplasia, and the decision for colectomy in chronic inflammatory boweldisease? ^1 |
Hookman, P.;Barkin, J.S.; |
The American Journal of Gastroenterology |
2002-05-01 |
查看 |
| Systemic autoimmune disorders associated with celiac disease (CD): a casereport |
Slate, J.A.;Hookman, P.;Phillips, R.S.;Barkin, J.S.; |
The American Journal of Gastroenterology |
2002-09-01 |
查看 |
| Response to Dr. Kadayifci |
Hookman, P.;Barkin, J.S.; |
The American Journal of Gastroenterology |
2003-10-01 |
查看 |
| Current biochemical studies of Non-Alcoholic Fatty Liver Disease (NAFLD)and Non-Alcoholic Steatohepatitis (NASH) suggest a new therapeutic approach- Lin Hz, Yang SQ, Chuckaree C, et al., Metformin's Reverses Fatty LiverDisease in Obese Leptin-Deficient Mice, Nature Medicine 2000;6(8):998-1003 |
Hookman, P.;Barkin, J.S.; |
The American Journal of Gastroenterology |
2003-02-01 |
查看 |
| Current biochemical studies of nonalcoholic fatty liver disease andnonalcoholic steatohepatitis suggest a new therapeutic approach: Lin HZ,Yang SQ, Chuckaree C, et al. Metformin reverses fatty liver disease inobese, Leptin-deficient Micenat Med 2000;6:998-1003 |
Hookman, P.;Barkin, J.S.; |
The American Journal of Gastroenterology |
2003-09-01 |
查看 |
|
|
